EU grants marketing approval to ALK’s EURneffy 1 mg, a needle-free adrenaline treatment for young children at risk of anaphylaxis: Denmark Thursday, April 2, 2026, 13:00 Hrs [IS ...

The ability to avoid routine needle carrying skyrocketed the value-based price (VBP) of nasal epinephrine to more than 1200% above baseline, according to new modeling data presented at the annual ...

Today, ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after the European ...

House Bill 533 and Senate Bill 351 would allow any FDA-approved epinephrine in Alabama schools, including needle-free options ...

Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of age to receive neffy 1 mg dose - approval ...

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

For people with sensitivity, encountering an allergen can within seconds turn into a respiratory emergency. This is what you need to know about using an auto-injector (Epipen) to save lives. An ...

Aspire Allergy & Sinus Dr. Haley Overstreet highlights new research on needle-free treatment for severe allergic reactions. Epinephrine saves lives—but too often, hesitation gets in the way. A ...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...

“These data offer robust insights into user preferences, showing a consistent preference for EURneffy ® over auto-injectors, even in participants with years of auto-injector experience,” said Dr ...

ALK, a global specialty pharmaceutical company, presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, ...